Prof. Linghua Li | Cancer Science | Best Researcher Award

Prof. Linghua Li | Cancer Science | Best Researcher Award

Guangzhou Eighth People’s Hospital | China

Author Profile

ORCID ID

🌟Linghua Li, Ph.D., M.S., B.S. 🌍

Head Director, Infectious Disease Center
Guangzhou Eighth People’s Hospital, Guangzhou Medical University

👩‍⚕️Biography

Dr. Linghua Li is a distinguished physician and researcher specializing in HIV/AIDS, infectious diseases, and oncology. With over 25 years of clinical experience, she has made significant contributions to understanding and managing infectious diseases, particularly fungal infections and HIV-related complications.

Dr. Li began her academic journey at the Medical School of Peking University, earning a B.S. in Clinical Medicine in 1997. She then pursued advanced studies at Sun Yat-sen University, completing an M.S. in Internal Medicine in 2008 and a Ph.D. in Infectious Diseases in 2011. She further enriched her expertise through visiting scholar positions at UNC-Chapel Hill (2012) and Duke University (2014), focusing on infectious diseases.

As the Head Director of the Infectious Disease Center at Guangzhou Eighth People’s Hospital, Dr. Li oversees clinical trials, patient care, and research initiatives for people living with HIV and at-risk populations. She has been principal investigator (PI) or co-investigator (Co-I) on more than 20 domestic and international research programs. Notable projects include:

  • National Natural Science Foundation of China (Grant No. 81301480): Investigating the mechanism and function of Phospholipase B in the growth and pathogenicity of P. marneffei.
  • Guangdong Natural Science Foundation (Grant No. 10151006002000000): Exploring the role of Phospholipase B in P. marneffei invasion of macrophages in AIDS patients.
  • NIH Fogarty Program: Examining host factors in severe opportunistic complications of AIDS, with a focus on developing targeted prophylactic strategies.

In recent years, Dr. Li has been a Co-PI on groundbreaking HIV PrEP Phase IV clinical trials in Guangzhou, including:

  • ChiCTR2100048981 and NCT04754139: These studies focus on scaling PrEP access for key populations in China. The trial successfully enrolled 1,007 participants by 2023, with 950 already on PrEP, marking it as the largest trial of its kind in China.

Dr. Li’s work emphasizes translational medicine, data-driven public health strategies, and the implementation of novel interventions like PrEP to curb HIV transmission. Her expertise in site coordination, implementation, data collection, and analysis has been pivotal to these efforts.

🧬Key Areas of Expertise

🔬 HIV Prevention and Treatment
🌿 Opportunistic Infections
📊 Clinical Trials and Data Analysis
🧑‍⚕️ Internal and Infectious Diseases

📚Academic Background

  • B.S., Clinical Medicine, Medical School of Peking University (1997)
  • M.S., Internal Medicine, Sun Yat-sen University (2008)
  • Ph.D., Infectious Diseases, Sun Yat-sen University (2011)
  • Visiting Scholar, UNC-Chapel Hill (2012)
  • Visiting Scholar, Duke University (2014)

🔬Research Impact

🌟 Over 20 funded research projects
📄 Numerous publications in infectious disease and public health journals
📚 Active contributor to advancing HIV prevention strategies in China

Dr. Linghua Li remains a leader in the fight against infectious diseases, with a career dedicated to improving global health outcomes. 🌏✨

✨ Conclusion

Dr. Linghua Li’s career exemplifies dedication to advancing the prevention, treatment, and understanding of infectious diseases, particularly HIV/AIDS and associated complications. Through her leadership, innovative research, and clinical expertise, she has significantly impacted global health, especially in developing effective interventions like PrEP for key populations in China. Her contributions to translational medicine and public health continue to pave the way for breakthroughs in managing infectious diseases and improving the lives of those affected worldwide. 🌟🌍

📊🔬NOTABLE PUBLICATION:
  • Utilizing Protein–Peptide Hybrid Microarray for Time-Resolved Diagnosis and Prognosis of COVID-19
    • Authors: Peiyan Zheng, Baolin Liao, Jiao Yang, Hu Cheng, Zhangkai Cheng, Huimin Huang, Wenting Luo, Yiyue Sun, Qiang Zhu, Yi Deng, et al.
    • Journal: Microorganisms
    • Year: 2023

Prof. Sobhi Gomha | Chemotherapy | Best Researcher Award

Prof. Sobhi Gomha | Chemotherapy | Best Researcher Award

Islamic University of Madinah | Saudi Arabia

Author Profile

Scopus

Google Scholar

Orcid id

Personal Data:

  • Name: Sobhi Mohamed Gomha
  • Date of Birth: 1972
  • Place of Birth: Fayoum, Egypt
  • Nationality: Egyptian
  • Gender and Marital Status: Male, Married
  • Occupation: Professor of Organic Chemistry
  • Institutions:
    • Faculty of Science, Cairo University, Giza, Egypt.
    • Faculty of Science, Islamic University of Madinah, Madinah, Saudi Arabia.
  • Addresses:
    • Permanent: Faculty of Science, Cairo University, Giza 12613, Egypt; Chemistry Department
    • Resident: Faculty of Science, Islamic University of Madinah, Madinah 42351, Saudi Arabia.
  • Contact:

Certificates and Qualifications:

  • B.Sc. (Chemistry): 1995, Cairo University – Faculty of Science.
  • Pre-master courses: 1996-1997
  • M.Sc. (Organic Chemistry): 2002, Cairo University – Faculty of Science.
  • Ph.D. (Organic Chemistry): 2006, Cairo University – Faculty of Science.
  • Associate Professor: January 2012, Cairo University – Faculty of Science.
  • Full Professor: January 2017, Cairo University – Faculty of Science.

Research Interests:

  • Green Synthesis: Focus on the green synthesis of novel heterocyclic compounds using eco-friendly technologies like Microwave Irradiation, Ultrasonic radiation, Grinding, and Ionic Liquids.
  • Applications: Biological and industrial applications with an emphasis on reducing hazardous substances and energy usage.

Online Profiles:

Publications and Metrics:

  • Total Publications: 270 (257 published papers: 240 research papers, 17 review articles) + 13 books.
  • Citations:
    • Google Scholar: 6730
    • Scopus: 5600
    • Web of Science: 6280
    • ResearchGate: 6050
  • Highly Cited Papers:
    • Google Scholar: 319
    • Scopus: 269
    • Web of Science: 250
    • ResearchGate: 269
  • H-index:
    • Google Scholar: 48
    • Scopus: 44
    • Web of Science: 44
    • ResearchGate: 43
  • i10-index: 176 (Google Scholar)

Teaching Courses:

  • General Chemistry, Aliphatic Organic Chemistry, Aromatic Organic Chemistry, Heterocyclic Chemistry, Functional Organic Chemistry, Physical Organic Chemistry, Biomolecules, Natural products, Organometallic Chemistry, Physical Pharmacy, Stereochemistry, Biochemistry, Advanced Heterocyclic Chemistry, Chemistry of Drugs, Green and Environmental Chemistry, Reactions and Mechanisms of Aliphatic Compounds, Spectroscopy (MS, IR, NMR, UV), Basic principles of Organic Chemistry for Pre-Pharmacy, Pre-Dental, Pre-Veterinary students, Practical Organic Chemistry for undergraduate students, Field Training, Graduation Project.

Professional Memberships and Achievements:

  • Scientific Societies:
    • Egyptian Society of Heterocyclic Chemistry (EHCS)
    • Performance appraisal and development committee (Cairo University)
    • Scientific culture committee (Cairo University)
    • Research Committee of the article and graduation projects (Cairo University)
    • Quality Committee, Department of Chemistry (Cairo University and Islamic University of Madinah)
    • Training and Development Committee, Faculty of Science, Islamic University of Madinah
    • Head of Chemistry Department, Faculty of Science, Islamic University of Madinah
    • Egyptian National Bioinformatics Network (BioNetMasr)
    • Scientific Research Deanship Council at the Islamic University
    • Sustainability Unit at the Islamic University
    • Supervised and launched academic programs and projects in Chemistry
    • Participated in numerous scientific and quality events

Conferences Attended:

  • Participated and presented in various international and national conferences, such as Biannual conference on chemistry (Cairo University), International conferences in Egypt, UAE, Morocco, and Saudi Arabia, Heterocyclic Chemistry meetings, Scientific Research Weeks, and Quality Weeks.

Experiences:

  • Proficient in PC software (ChemDraw, Excel, Word, PowerPoint)
  • Expertise in Mass Spectra, NMR, Organic Synthesis
  • Completed various training courses in IR, NMR, UV, GCMS, microanalytical instruments, effective presentation, new trends in teaching (E-Learning), effective teaching, credit hours education, scientific publications, utility of technology in teaching, and strategic planning.

Editorial and Reviewer Roles:

  • Editorial Board Member for 42 Journals: Including Molecules, Crystals, Scientific Reports, Mini-Reviews in Medicinal Chemistry, Current Medicinal Chemistry, and various other international journals.
  • Reviewer for 138 Journals: Including ACS Chemical Neuroscience, Acta Pharmaceutica Sinica B, Analytical Chemistry Letters, Anticancer Agents in Medicinal Chemistry, Arabian Journal of Chemistry, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, and many more.

Reviewing PhD Theses:

  • Reviewed several PhD theses on topics like environmental cost accounting, synthesis and biological evaluation of novel compounds, green chemistry methodologies, and heterocyclic ring synthesis.

Reviewing for Promotions:

  • Reviewed scientific production for the promotion of faculty members from various universities, including Imam Abdulrahman Bin Faisal University, University of Bisha, Northern Border University, Taibah University, Taif University, and Tabuk University.

Languages:

  • English (Good), French (Fair), German (Fair)

Supervision:

  • Supervisor for 17 MSc and 9 PhD theses.

Research Projects:

  • Engaged in multiple research projects funded by various institutions, focusing on green synthesis, characterization, biological evaluation of novel compounds, separation of rare earth elements, and innovative optical organic compounds for solar cells.

Awards and Recognition:

  • Best paper in heterocyclic chemistry from the Egyptian Heterocyclic Chemistry Society (E.H.C.S) for 2015.
  • Included in the list of the World’s Top 2% Scientists by Stanford University for the years 2019, 2020, and 2021.

Notable Publication:

Assoc Prof Dr. Zhijie Xu | Chemotherapy | Best Researcher Award

Assoc Prof Dr. Zhijie Xu | Chemotherapy | Best Researcher Award 

Xiangya Hospital Central South University | China

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Zhijie Xu embarked on his academic journey with a solid foundation in medical laboratory science, earning his bachelor’s degree from Xiangya School of Medicine. His early interests focused on the mechanisms of disease at the cellular level, laying the groundwork for his future research endeavors.

PROFESSIONAL ENDEAVORS

Throughout his career, Zhijie Xu has held notable positions, including Associate Professor and Associate Chief Technician at Xiangya Hospital, Central South University. His professional roles have been complemented by his extensive involvement in editorial activities for prominent scientific journals, which underscores his influence in the field of oncology and pharmacology.

CONTRIBUTIONS AND RESEARCH FOCUS ON CHEMOTHERAPY

Zhijie Xu’s research has predominantly centered on the molecular and cellular mechanisms of cancer. His work has particularly focused on DNA-damage response, ubiquitination in human cancers, and cell autophagy related to radio-resistance in cancers. His contributions to understanding non-coding RNA and immunotherapy in lung cancers and gliomas are notable.

IMPACT AND INFLUENCE

With an H index of 30, Zhijie Xu’s research has had a significant impact on the scientific community. His findings have provided insights into the molecular underpinnings of cancer, influencing both basic and clinical cancer research. His editorial roles further amplify his influence, as he shapes the discourse in several high-impact journals.

ACADEMIC CITES

Zhijie Xu’s academic work is well-cited, reflecting the importance and relevance of his research. His contributions to understanding the complex mechanisms of cancer biology have been recognized and referenced by peers, solidifying his reputation in the scientific community.

LEGACY AND FUTURE CONTRIBUTIONS

Looking forward, Zhijie Xu aims to continue his groundbreaking research in cancer biology. His future work is expected to delve deeper into the mechanisms of cancer resistance and the development of novel therapeutic strategies. His ongoing projects and future initiatives are poised to further advance the field and contribute to the fight against cancer.

 

NOTABLE PUBLICATION: